AEON
AEON Biopharma, Inc.
Price Chart
Latest Quote
$0.72
-0.02 (-2.12%)
Current Price
| Previous Close | $0.74 |
| Open | $0.73 |
| Day High | $0.74 |
| Day Low | $0.72 |
| Volume | 14,175 |
Stock Information
| Shares Outstanding | 26.31M |
| Total Debt | $2.37M |
| Cash Equivalents | $6.24M |
| Net Income | $-60.11M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $18.99M |
| EPS (TTM) | $-6.52 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $15.11M |
| Income | $-60.11M |
| Book/sh | $-0.66 |
| Cash/sh | $0.24 |
| Employees | 8 |
Financial Ratios
| Quick Ratio | 0.94 |
| Current Ratio | 0.99 |
Returns & Margins
| ROA | -101.93% |
Ownership
| Insider Ownership | 85.37% |
| Institutional Ownership | 7.50% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.05 |
| P/B | -1.09 |
Analyst Data
| Recommendation | none |
| Target Price | $6.70 |
Technical Indicators
| SMA20 | $0.79 |
| SMA50 | $0.90 |
| SMA200 | $0.95 |
| RSI | 50.00 |
| ATR | 0.0456 |
| Shares Float | 11.73M |
| Short Float | 1.66% |
| Short Ratio | 1.82 |
| Rel Volume | 0.30 |
Performance History
| Week | -4.62% |
| Month | -20.31% |
| Quarter | -31.89% |
| 6 Months | -11.41% |
| YTD | -34.95% |
| Year | +10.23% |
| 3 Years | -99.90% |
| 10 Years | -99.90% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $0.72 | 18,200 |
| 2026-06-04 | $0.74 | 16,600 |
| 2026-06-03 | $0.73 | 9,500 |
| 2026-06-02 | $0.75 | 18,800 |
| 2026-06-01 | $0.75 | 27,400 |
| 2026-05-29 | $0.76 | 34,300 |
| 2026-05-28 | $0.72 | 44,000 |
| 2026-05-27 | $0.75 | 16,300 |
| 2026-05-26 | $0.77 | 62,200 |
| 2026-05-22 | $0.78 | 133,700 |
| 2026-05-21 | $0.82 | 39,000 |
| 2026-05-20 | $0.86 | 37,000 |
| 2026-05-19 | $0.86 | 29,400 |
| 2026-05-18 | $0.86 | 255,300 |
| 2026-05-15 | $0.72 | 95,900 |
| 2026-05-14 | $0.80 | 32,100 |
| 2026-05-13 | $0.82 | 162,100 |
| 2026-05-12 | $0.88 | 15,300 |
| 2026-05-11 | $0.88 | 85,500 |
| 2026-05-08 | $0.90 | 61,800 |
| 2026-05-07 | $0.91 | 24,000 |
| 2026-05-06 | $0.91 | 62,000 |
About AEON Biopharma, Inc.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
đ° Latest News
Why You Might Be Interested In Aeon Co. (M) Bhd. (KLSE:AEON) For Its Upcoming Dividend
Simply Wall St. âĸ 2026-05-25T00:02:20Z
Aeon Biopharma announces FDA feedback after Type 2a meeting
TipRanks âĸ 2026-03-26T12:17:47Z
An Intrinsic Calculation For Aeon Co. (M) Bhd. (KLSE:AEON) Suggests It's 42% Undervalued
Simply Wall St. âĸ 2026-01-14T07:37:23Z
Investors in Aeon (M) Bhd (KLSE:AEON) have unfortunately lost 24% over the last year
Simply Wall St. âĸ 2025-12-15T02:14:04Z
The Returns At Aeon (M) Bhd (KLSE:AEON) Aren't Growing
Simply Wall St. âĸ 2025-10-22T06:14:57Z
Aeon Co. (M) Bhd.'s (KLSE:AEON) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Simply Wall St. âĸ 2025-09-29T00:02:01Z
Aeon Co. (M) Bhd.'s (KLSE:AEON) largest shareholders are public companies with 52% ownership, institutions own 33%
Simply Wall St. âĸ 2025-09-12T03:41:25Z
Aeon (M) Bhd Second Quarter 2025 Earnings: EPS: RM0.009 (vs RM0.02 in 2Q 2024)
Simply Wall St. âĸ 2025-08-26T22:11:29Z
Are Investors Undervaluing Aeon Co. (M) Bhd. (KLSE:AEON) By 39%?
Simply Wall St. âĸ 2025-08-07T06:07:33Z
Those who invested in Aeon (M) Bhd (KLSE:AEON) five years ago are up 66%
Simply Wall St. âĸ 2025-07-07T07:17:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | - | $0 |
| Operating Revenue | $0 | $0 | - | $0 |
| Expenses | ||||
| Total Expenses | $16,302,000 | $27,824,000 | - | $48,429,000 |
| Other Income Expense | $-22,920,000 | $69,829,000 | - | $-4,127,000 |
| Other Non Operating Income Expenses | $-75,354,000 | $95,000 | - | $289,000 |
| Operating Expense | $16,302,000 | $27,824,000 | - | $48,429,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Normalized Income | $-91,656,000 | $-27,729,000 | - | $-48,140,000 |
| Net Income From Continuing And Discontinued Operation | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Total Operating Income As Reported | $-12,803,000 | $72,985,000 | - | $-48,429,000 |
| Net Income Common Stockholders | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Net Income | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Net Income Including Noncontrolling Interests | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Net Income Continuous Operations | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Pretax Income | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Special Income Charges | $3,499,000 | $100,809,000 | - | $0 |
| Operating Income | $-16,302,000 | $-27,824,000 | - | $-48,429,000 |
| Per Share | ||||
| Diluted EPS | $-3.95 | $72.93 | - | $-172.03 |
| Basic EPS | $-3.95 | $77.74 | - | $-172.03 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | - | $0 |
| Tax Rate For Calcs | $0 | $0 | - | $0 |
| Normalized EBITDA (Bullshit earnings) | $-68,658,000 | $-97,461,000 | - | $-43,945,000 |
| Total Unusual Items | $52,434,000 | $69,734,000 | - | $-4,416,000 |
| Total Unusual Items Excluding Goodwill | $52,434,000 | $69,734,000 | - | $-4,416,000 |
| Reconciled Depreciation | $78,000 | $97,000 | - | $68,000 |
| EBITDA (Bullshit earnings) | $-16,224,000 | $-27,727,000 | - | $-48,361,000 |
| EBIT | $-16,302,000 | $-27,824,000 | - | $-48,429,000 |
| Diluted Average Shares | $9,921,587 | $575,945 | $516,105 | $305,501 |
| Basic Average Shares | $9,921,587 | $540,359 | $516,105 | $305,501 |
| Diluted NI Availto Com Stockholders | $-39,222,000 | $42,005,000 | - | $-52,556,000 |
| Tax Provision | $0 | $0 | - | $0 |
| Restructuring And Mergern Acquisition | $-3,499,000 | $-100,809,000 | - | $0 |
| Gain On Sale Of Security | $48,935,000 | $-31,075,000 | - | $-4,416,000 |
| Research And Development | $4,094,000 | $14,181,000 | - | $34,754,000 |
| Selling General And Administration | $12,208,000 | $13,643,000 | - | $13,675,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-55,027,000 | $-28,569,000 | $-153,044,000 | $-287,500,000 |
| Total Assets | $5,560,000 | $3,142,000 | $6,845,000 | $10,778,000 |
| Total Non Current Assets | $2,162,000 | $1,552,000 | $623,000 | $940,000 |
| Other Non Current Assets | $948,000 | $29,000 | $29,000 | $34,000 |
| Current Assets | $3,398,000 | $1,590,000 | $6,222,000 | $9,838,000 |
| Other Current Assets | $392,000 | $1,577,000 | $1,064,000 | $92,000 |
| Cash Cash Equivalents And Short Term Investments | $3,006,000 | $13,000 | $5,158,000 | $9,746,000 |
| Cash And Cash Equivalents | $3,006,000 | $13,000 | $5,158,000 | $9,746,000 |
| Cash Financial | - | - | $5,158,000 | $9,746,000 |
| Debt | ||||
| Net Debt | $31,594,000 | $11,676,000 | - | $121,546,000 |
| Total Debt | $35,745,000 | $12,955,000 | $278,000 | $131,791,000 |
| Long Term Debt And Capital Lease Obligation | $35,493,000 | $12,834,000 | $0 | $60,668,000 |
| Long Term Debt | $34,600,000 | $11,689,000 | - | $60,426,000 |
| Current Debt And Capital Lease Obligation | $252,000 | $121,000 | $278,000 | $71,123,000 |
| Current Debt | - | - | - | $70,866,000 |
| Other Current Borrowings | - | - | - | $70,866,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $60,587,000 | $31,711,000 | $159,889,000 | $281,191,000 |
| Total Non Current Liabilities Net Minority Interest | $53,690,000 | $17,562,000 | $146,840,000 | $198,617,000 |
| Other Non Current Liabilities | $42,000 | $3,541,000 | $104,350,000 | - |
| Derivative Product Liabilities | $18,155,000 | $1,187,000 | $42,490,000 | $0 |
| Current Liabilities | $6,897,000 | $14,149,000 | $13,049,000 | $82,574,000 |
| Payables And Accrued Expenses | $3,773,000 | $12,960,000 | $11,828,000 | $10,339,000 |
| Payables | $1,511,000 | $6,479,000 | $3,957,000 | $7,805,000 |
| Total Tax Payable | $569,000 | $569,000 | $569,000 | $0 |
| Accounts Payable | $942,000 | $5,910,000 | $3,388,000 | $7,805,000 |
| Equity | ||||
| Common Stock Equity | $-55,027,000 | $-28,569,000 | $-153,044,000 | $-287,500,000 |
| Total Equity Gross Minority Interest | $-55,027,000 | $-28,569,000 | $-153,044,000 | $-270,413,000 |
| Stockholders Equity | $-55,027,000 | $-28,569,000 | $-153,044,000 | $-287,500,000 |
| Retained Earnings | $-470,819,000 | $-431,597,000 | $-473,602,000 | $-474,839,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $0 | $137,949,000 |
| Other Equity Interest | - | - | $-60,710,000 | - |
| Other | ||||
| Ordinary Shares Number | $12,105,902 | $555,511 | $516,105 | $380,982 |
| Share Issued | $12,105,902 | $555,511 | $516,105 | $380,982 |
| Tangible Book Value | $-55,027,000 | $-28,569,000 | $-153,044,000 | $-287,500,000 |
| Invested Capital | $-20,427,000 | $-16,880,000 | $-153,044,000 | $-156,208,000 |
| Working Capital | $-3,499,000 | $-12,559,000 | $-6,827,000 | $-72,736,000 |
| Capital Lease Obligations | $1,145,000 | $1,266,000 | $278,000 | $499,000 |
| Total Capitalization | $-20,427,000 | $-16,880,000 | $-153,044,000 | $-227,074,000 |
| Additional Paid In Capital | $415,783,000 | $403,024,000 | $381,264,000 | $187,348,000 |
| Capital Stock | $9,000 | $4,000 | $4,000 | $14,000 |
| Common Stock | $9,000 | $4,000 | $4,000 | $14,000 |
| Long Term Capital Lease Obligation | $893,000 | $1,145,000 | $0 | $242,000 |
| Current Capital Lease Obligation | $252,000 | $121,000 | $278,000 | $257,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,872,000 | $1,068,000 | $943,000 | $1,112,000 |
| Current Accrued Expenses | $2,262,000 | $6,481,000 | $7,871,000 | $2,534,000 |
| Net PPE | $1,214,000 | $1,523,000 | $594,000 | $906,000 |
| Accumulated Depreciation | $-344,000 | $-267,000 | $-170,000 | $-71,000 |
| Gross PPE | $1,558,000 | $1,790,000 | $764,000 | $977,000 |
| Leases | $66,000 | $66,000 | $66,000 | $66,000 |
| Other Properties | $241,000 | $237,000 | $237,000 | $237,000 |
| Machinery Furniture Equipment | $199,000 | $199,000 | $199,000 | $199,000 |
| Buildings And Improvements | $1,052,000 | $1,288,000 | $262,000 | $475,000 |
| Properties | $0 | $0 | $0 | $0 |
| Minority Interest | - | $0 | $0 | $17,087,000 |
| Treasury Stock | - | $0 | $0 | $23,000 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,312,000 | $-20,292,000 | $-35,890,000 | $-28,603,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-17,308,000 | $-20,292,000 | $-35,584,000 | $-28,433,000 |
| Cash Flow From Continuing Operating Activities | $-17,308,000 | $-20,292,000 | $-35,584,000 | $-28,433,000 |
| Operating Gains Losses | $3,798,000 | $34,386,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-4,000 | - | $-306,000 | $-170,000 |
| Investing Cash Flow | $-4,000 | $0 | $-306,000 | $-170,000 |
| Cash Flow From Continuing Investing Activities | $-4,000 | $0 | $-306,000 | $-170,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $18,514,000 | $147,000 | - | - |
| Financing Cash Flow | $20,305,000 | $15,147,000 | $40,508,000 | $13,563,000 |
| Cash Flow From Continuing Financing Activities | $20,305,000 | $15,147,000 | $40,508,000 | $13,563,000 |
| Net Other Financing Charges | $1,791,000 | - | - | $-1,437,000 |
| Net Common Stock Issuance | $18,514,000 | $147,000 | - | - |
| Common Stock Issuance | $18,514,000 | $147,000 | - | - |
| Other | ||||
| Issuance Of Debt | $0 | $15,000,000 | $44,500,000 | $15,000,000 |
| End Cash Position | $3,006,000 | $13,000 | $9,746,000 | $5,128,000 |
| Beginning Cash Position | $13,000 | $5,158,000 | $5,128,000 | $20,168,000 |
| Changes In Cash | $2,993,000 | $-5,145,000 | $4,618,000 | $-15,040,000 |
| Net Issuance Payments Of Debt | $0 | $15,000,000 | $40,508,000 | $15,000,000 |
| Net Long Term Debt Issuance | $0 | $15,000,000 | $40,508,000 | $15,000,000 |
| Long Term Debt Issuance | $0 | $15,000,000 | $44,500,000 | $15,000,000 |
| Net PPE Purchase And Sale | $-4,000 | $0 | $-306,000 | $-170,000 |
| Purchase Of PPE | $-4,000 | $0 | $-306,000 | $-170,000 |
| Change In Working Capital | $-6,941,000 | $706,000 | $6,268,000 | $1,416,000 |
| Change In Other Working Capital | $-952,000 | $120,000 | $-174,000 | $-26,000 |
| Change In Payables And Accrued Expense | $-7,174,000 | $1,099,000 | $6,508,000 | $1,260,000 |
| Change In Accrued Expense | $-2,206,000 | $-1,423,000 | $-105,000 | $2,158,000 |
| Change In Payable | $-4,968,000 | $2,522,000 | $6,613,000 | $-898,000 |
| Change In Account Payable | $-4,968,000 | $2,522,000 | $6,613,000 | $-898,000 |
| Change In Prepaid Assets | $1,185,000 | $-513,000 | $-66,000 | $182,000 |
| Other Non Cash Items | $19,662,000 | $-103,736,000 | $4,413,000 | $18,587,000 |
| Stock Based Compensation | $5,317,000 | $6,250,000 | $5,892,000 | $5,220,000 |
| Depreciation Amortization Depletion | $78,000 | $97,000 | $68,000 | $3,000 |
| Depreciation And Amortization | $78,000 | $97,000 | $68,000 | $3,000 |
| Depreciation | $78,000 | $97,000 | $68,000 | $3,000 |
| Gain Loss On Investment Securities | $3,798,000 | $34,386,000 | - | - |
| Net Income From Continuing Operations | $-39,222,000 | $42,005,000 | $-52,556,000 | $-55,637,000 |
| Repayment Of Debt | - | - | $-3,992,000 | $0 |
| Long Term Debt Payments | - | - | $-3,992,000 | $0 |
| Unrealized Gain Loss On Investment Securities | - | - | $4,416,000 | $-795,000 |
| Asset Impairment Charge | - | - | $331,000 | $1,978,000 |
Fetched: 2026-06-02